The Lancet Microbe
订阅
1. [Comment] Importance of investing time and money in integrating large language model-based agents into outbreak analytics pipelines Albert Jan van Hoek, Sebastian Funk, Stefan Flasche, Billy J Quilty, Esther van Kleef, Anton Camacho, Adam J Kucharski
2. [Correspondence] Additional breastfeeding data essential to better understand kinetics of A (H1N1) pdm09 strain-specific antibodies induced by placental transfer and natural infection in children from birth to 3 years of age Yulei Li
3. [Articles] SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, Christine Lee, Melanie D McCauley, Ivelese Guzman, Christopher Bryant, Sarah McGuire, Jessie Kennedy, Wei-Hung Chen, Agnes Hajduczki, Thembi Mdluli, Anais Valencia-Ruiz, Mihret F Amare, Gary R Matyas, Mangala Rao, Morgane Rolland, John R Mascola, Stephen C De Rosa, M Juliana McElrath, David C Montefiori, Leonid Serebryannyy, Adrian B McDermott, Sheila A Peel, Natalie D Collins, M Gordon Joyce, Merlin L Robb, Nelson L Michael, Sandhya Vasan, Kayvon Modjarrad, EID-030 Study Group
4. [Articles] Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study Valentin Joste, Romain Coppée, Justine Bailly, Yann Rakotoarivony, Francine Ghislaine Toko Tchokoteu, Shany Achache, Bruno Pradines, Gilles Cottrell, Frédéric Ariey, Nimol Khim, Jean Popovici, Toshihiro Mita, Mirjam Groger, Michael Ramharter, Timothy Egbo, Dennis W Juma, Hoseah Akala, Sandrine Houzé, Jérôme Clain, Investigation Study Group
5. [Comment] To vaccinate or not against highly pathogenic avian influenza? Krishna Prasad Acharya, Sarita Phuyal
6. [Correspondence] Harmonising the measurement of neutralising antibodies against chikungunya virus: a path forward for licensing of new vaccines? Sally A Baylis, Ivana Knezevic, Neil M Almond
7. [Articles] SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study Leonie Meiners, Johanna Horn, Terry C Jones, Barbara Mühlemann, Marie Luisa Schmidt, Felix Walper, Peter Menzel, Rolf Schwarzer, Ruben Rose, Andi Krumbholz, Victor M Corman, Joachim Seybold, Christian Drosten
8. [Correspondence] A rapid test using a single drop of blood to screen for schistosomiasis in non-endemic countries Zeno Bisoffi, Stefania Varani, Bianca Granozzi, Silvia Stefania Longoni, Margherita Ortalli
9. [Comment] Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses? Nicola Douglass
10. [Articles] Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study Edwin P Armitage, Gabrielle de Crombrugghe, Alexander J Keeley, Elina Senghore, Fatoumata E Camara, Musukoi Jammeh, Amat Bittaye, Haddy Ceesay, Isatou Ceesay, Bunja Samateh, Muhammed Manneh, Beate Kampmann, Claire E Turner, Adam Kucharski, Anne Botteaux, Pierre R Smeesters, Thushan I de Silva, Michael Marks, MRCG StrepA Study Group
11. [Review] Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles Stephen H Gillespie, Andrew R DiNardo, Sophia B Georghiou, Wilber Sabiiti, Mikashmi Kohli, Ursula Panzner, Irina Kontsevaya, Norbert Hittel, Lieven J Stuyver, Jia Bin Tan, Reinout van Crevel, Christoph Lange, Thuong Nguyen Thuy Thuong, Jan Heyckendorf, Morten Ruhwald, Norbert Heinrich
12. [Comment] Pooled profiling of natural Mycobacterium tuberculosis diversity: linking genes, bacterial behaviours, and clinical outcomes Lucas Boeck
13. [Articles] Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains Sydney Stanley, Caitlin N Spaulding, Qingyun Liu, Michael R Chase, Dang Thi Minh Ha, Phan Vuong Khac Thai, Nguyen Huu Lan, Do Dang Anh Thu, Nguyen Le Quang, Jessica Brown, Nathan D Hicks, Xin Wang, Maximillian Marin, Nicole C Howard, Andrew J Vickers, Wiktor M Karpinski, Michael C Chao, Maha R Farhat, Maxine Caws, Sarah J Dunstan, Nguyen Thuy Thuong Thuong, Sarah M Fortune
14. [Correspondence] Used antigenic devices as a matrix for molecular detection of respiratory viruses Jean-Michel Mansuy, Emma Da Horta, Camille Bréhin, Isabelle Claudet, Pauline Trémeaux
15. [Articles] Effect of human H3N2 influenza virus reassortment on influenza incidence and severity during the 2017–18 influenza season in the USA: a retrospective observational genomic analysis Hsuan Liu, Kathryn Shaw-Saliba, Jason Westerbeck, David Jacobs, Katherine Fenstermacher, Chia-Yu Chao, Yu-Nong Gong, Harrison Powell, Zexu Ma, Thomas Mehoke, Amanda W Ernlund, Amanda Dziedzic, Siddhant Vyas, Jared Evans, Lauren M Sauer, Chin-Chieh Wu, Shu-Hui Chen, Richard E Rothman, Peter Thielen, Kuan-Fu Chen, Andrew Pekosz
16. [Review] Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases Saverio Caini, Adam Meijer, Marta C Nunes, Laetitia Henaff, Malaika Zounon, Bronke Boudewijns, Marco Del Riccio, John Paget
17. [Articles] Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study Thomas G Evans, Flora Castellino, Monika Kowalik Dobczyk, Gwen Tucker, Ana Marie Walley, Katrin Van Leuven, Jelle Klein, Kathryn Rutkowski, Chris Ellis, Elizabeth Eagling-Vose, John Treanor, Carel van Baalen, Ella Filkov, Cyril Laurent, Juilee Thacker, Jason Asher, Armen Donabedian
18. [Correspondence] Additional thoughts on group A streptococci Dingle Yu, Yuejie Zheng, George Fu Gao, Yonghong Yang
19. [Articles] Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali Almahamoudou Mahamar, Merel J Smit, Koualy Sanogo, Youssouf Sinaba, Sidi M Niambele, Adama Sacko, Oumar M Dicko, Makonon Diallo, Seydina O Maguiraga, Yaya Sankaré, Sekouba Keita, Siaka Samake, Adama Dembele, Kjerstin Lanke, Rob ter Heine, John Bradley, Yahia Dicko, Sekou F Traore, Chris Drakeley, Alassane Dicko, Teun Bousema, Will Stone
20. [Articles] Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study Susan Jackson, Julia L Marshall, Andrew Mawer, Raquel Lopez-Ramon, Stephanie A Harris, Iman Satti, Eileen Hughes, Hannah Preston-Jones, Ingrid Cabrera Puig, Stephanie Longet, Tom Tipton, Stephen Laidlaw, Rebecca Powell Doherty, Hazel Morrison, Robert Mitchell, Rachel Tanner, Alberta Ateere, Elena Stylianou, Meng-San Wu, Timothy P W Fredsgaard-Jones, Judith Breuer, Garth Rapeport, Vanessa M Ferreira, Fergus Gleeson, Andrew J Pollard, Miles Carroll, Andrew Catchpole, Christopher Chiu, Helen McShane, COV-CHIM01 study team
21. [Articles] Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case–control study Annika Saukkoriipi, Natalie C Silmon de Monerri, Maija Toropainen, Laura Lindholm, Riitta Veijola, Jorma Toppari, Mikael Knip, David Radley, Emily Gomme, Babalwa Jongihlati, Annaliesa S Anderson, Arto A Palmu, Raphael Simon
22. [Articles] Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study Rémy A Bonnin, Elodie Creton, Amandine Perrin, Delphine Girlich, Cecile Emeraud, Agnès B Jousset, Mathilde Duque, Aymeric Jacquemin, Katie Hopkins, Pierre Bogaerts, Youri Glupczynski, Niels Pfennigwerth, Marek Gniadkowski, Antoni P A Hendrickx, Kim van der Zwaluw, Petra Apfalter, Rainer Hartl, Vendula Studentova, Jaroslav Hrabak, Gerald Larrouy-Maumus, Eduardo P C Rocha, Thierry Naas, Laurent Dortet
23. [Correspondence] Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition Soraya Maria Menezes, Marc Jamoulle, Maria Paula Carletto, Leen Moens, Isabelle Meyts, Piet Maes, Johan Van Weyenbergh
24. [Correspondence] Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis Florian Reizine, Jean-Marc Tadié, Murielle Grégoire, Karin Tarte, Jean-Pierre Gangneux
25. [Comment] Epidemiology of group A streptococcal infection: are we ready for a new scenario? Miriam Massese, Marilena La Sorda, Flavio De Maio, Antonio Gatto, Roberto Rosato, Valeria Pansini, Anya Caroselli, Barbara Fiori, Maurizio Sanguinetti, Antonio Chiaretti, Brunella Posteraro
26. [Comment] Shared immunogenic epitopes between host entry and exit proteins from monkeypox and Alaskapox viruses Leonardo Pereira de Araújo, Evandro Neves Silva, Patrícia Paiva Corsetti, Leonardo Augusto de Almeida
27. [Correspondence] Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China Yan Chen, Xi Li, Ying Fu, Yunsong Yu, Hua Zhou
28. [Comment] Risks of releasing imperfect Wolbachia strains for arbovirus control Henrik Salje, Francis M Jiggins
29. [Personal View] Integrating research on bacterial pathogens and commensals to fight infections—an ecological perspective Lisa Maier, Christoph Stein-Thoeringer, Ruth E Ley, Heike Brötz-Oesterhelt, Hannes Link, Nadine Ziemert, Samuel Wagner, Andreas Peschel
30. [Personal View] The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation Giacomo Casalini, Andrea Giacomelli, Spinello Antinori
31. [Articles] Xpert MTB/RIF Ultra versus mycobacterial growth indicator tube liquid culture for detection of Mycobacterium tuberculosis in symptomatic adults: a diagnostic accuracy study Yingda L Xie, Christie Eichberg, Nchimunya Hapeela, Elizabeth Nakabugo, Irene Anyango, Kiranjot Arora, Jeffrey E Korte, Ronald Odero, Judi van Heerden, Widaad Zemanay, Samuel Kennedy, Pamela Nabeta, Mahmud Hanif, Camilla Rodrigues, Alena Skrahina, Wendy Stevens, Reynaldo Dietze, Xin Liu, Jerrold J Ellner, David Alland, Moses L Joloba, Samuel G Schumacher, Kimberly D McCarthy, Lydia Nakiyingi, Susan E Dorman
32. [Review] Infectious diseases and the role of needle biopsy post-mortem Lucia Molinengo, Theodore Estrin-Serlui, Brian Hanley, Michael Osborn, Robert Goldin
33. [Correspondence] Concerted efforts toward genomic surveillance of viral pathogens in immunocompromised individuals Matheus Filgueira Bezerra, Gabriel da Luz Wallau
34. [Correspondence] Are low-income and middle-income countries being neglected in genomic surveillance of the emergence and spread of multidrug-resistant Enterobacterales? Dennis Nurjadi, Sébastien Boutin, Thirumalaisamy P Velavan
35. [Articles] Seroprevalence of Bas-Congo virus in Mangala, Democratic Republic of the Congo: a population-based cross-sectional study Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Takanari Hattori, Takeshi Saito, Boniface Pongombo Lombe, Hiroko Miyamoto, Akina Mori-Kajihara, Masahiro Kajihara, Agathe Bikupe Nkoy, Augustin Tshibwabwa Twabela, Justin Masumu, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Manabu Igarashi, Eun-sil Park, Shigeru Morikawa, Sheila Makiala-Mandanda, Ayato Takada
36. [Correspondence] Distribution of IncX3 plasmids in bacteria Yu Feng, Zhiyong Zong
37. [Correspondence] Distribution of IncX3 plasmids in bacteria – Authors’ reply Qiu E Yang, Shungui Zhou, Timothy R Walsh
38. [Review] Impact of climate change and natural disasters on fungal infections Danila Seidel, Sebastian Wurster, Jeffrey D Jenks, Hatim Sati, Jean-Pierre Gangneux, Matthias Egger, Ana Alastruey-Izquierdo, Nathan P Ford, Anuradha Chowdhary, Rosanne Sprute, Oliver Cornely, George R Thompson, Martin Hoenigl, Dimitrios P Kontoyiannis
39. [Review] Staphylococcus aureus colonisation and strategies for decolonisation Pipat Piewngam, Michael Otto
40. [News] AI-assisted HIV case finding in Ukraine Ed Holt
41. [News] Routine malaria vaccinations start in Africa Priya Venkatesan
42. [Correspondence] Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring Rhoda Cheuk-Ying Leung, Jonathan Daniel Ip, Lin-Lei Chen, Wan-Mui Chan, Kelvin Kai-Wang To
43. [Comment] Multicentre, cross-sectional surveillance of Helicobacter pylori prevalence and antibiotic resistance to clarithromycin and levofloxacin in urban China using the string test coupled with quantitative PCR Liang Wang, Zhengkang Li, Chin Yen Tay, Barry J Marshall, Bing Gu, Guangdong Center for Quality Control of Clinical Gene Testing and Study Group of Chinese Helicobacter pylori Infection and Antibiotic Resistance Rates Mapping Project (CHINAR-MAP)
44. [News] Remote First Nations communities face climate change pressures Georgina Kenyon
45. [Correspondence] Mining Staphylococcus aureus genomic data for identifying fosfomycin resistance genes Yiyi Chen, Yueqin Hong, Lu Sun, Yunsong Yu, Yan Chen
46. [Correspondence] Comprehensive examination of travel-related antimicrobial resistance and the gut microbiome Yu Sun, Xi Fu
47. [Correspondence] Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae Patrick M Meyer Sauteur, Michael L Beeton, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group
48. [Correspondence] The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2 Pei Du, Chunli Wu, Shixiong Hu, Rui Fan, George Fu Gao, Qihui Wang
49. [Correspondence] Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China Heng Li, Shengkai Li, Huajiang Yang, Zhengrong Chen, Zhemin Zhou
更新于 34 分钟前

近期历史最近 100 条记录

2024-05-17 [Comment] Importance of investing time and money in integrating large language model-based agents into outbreak analytics pipelines Albert Jan van Hoek, Sebastian Funk, Stefan Flasche, Billy J Quilty, Esther van Kleef, Anton Camacho, Adam J Kucharski
2024-05-16 [Correspondence] Additional breastfeeding data essential to better understand kinetics of A (H1N1) pdm09 strain-specific antibodies induced by placental transfer and natural infection in children from birth to 3 years of age Yulei Li
2024-05-15 [Articles] SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, Christine Lee, Melanie D McCauley, Ivelese Guzman, Christopher Bryant, Sarah McGuire, Jessie Kennedy, Wei-Hung Chen, Agnes Hajduczki, Thembi Mdluli, Anais Valencia-Ruiz, Mihret F Amare, Gary R Matyas,
2024-05-15 [Articles] Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study Valentin Joste, Romain Coppée, Justine Bailly, Yann Rakotoarivony, Francine Ghislaine Toko Tchokoteu, Shany Achache, Bruno Pradines, Gilles Cottrell, Frédéric Ariey, Nimol Khim, Jean Popovici, Toshihiro Mita, Mirjam Groger, Michael Ramharter, Timothy Egbo
2024-05-15 [Comment] To vaccinate or not against highly pathogenic avian influenza? Krishna Prasad Acharya, Sarita Phuyal
2024-05-15 [Correspondence] Harmonising the measurement of neutralising antibodies against chikungunya virus: a path forward for licensing of new vaccines? Sally A Baylis, Ivana Knezevic, Neil M Almond
2024-05-14 [Articles] SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study Leonie Meiners, Johanna Horn, Terry C Jones, Barbara Mühlemann, Marie Luisa Schmidt, Felix Walper, Peter Menzel, Rolf Schwarzer, Ruben Rose, Andi Krumbholz, Victor M Corman, Joachim Seybold, Christian Drosten
2024-05-13 [Correspondence] A rapid test using a single drop of blood to screen for schistosomiasis in non-endemic countries Zeno Bisoffi, Stefania Varani, Bianca Granozzi, Silvia Stefania Longoni, Margherita Ortalli
2024-05-10 [Comment] Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses? Nicola Douglass
2024-05-09 [Articles] Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study Edwin P Armitage, Gabrielle de Crombrugghe, Alexander J Keeley, Elina Senghore, Fatoumata E Camara, Musukoi Jammeh, Amat Bittaye, Haddy Ceesay, Isatou Ceesay, Bunja Samateh, Muhammed Manneh, Beate Kampmann, Claire E Turner, Adam Kucharski, Anne Botteaux,
2024-05-09 [Review] Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles Stephen H Gillespie, Andrew R DiNardo, Sophia B Georghiou, Wilber Sabiiti, Mikashmi Kohli, Ursula Panzner, Irina Kontsevaya, Norbert Hittel, Lieven J Stuyver, Jia Bin Tan, Reinout van Crevel, Christoph Lange, Thuong Nguyen Thuy Thuong, Jan Heyckendorf, Mo
2024-05-09 [Articles] Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains Sydney Stanley, Caitlin N Spaulding, Qingyun Liu, Michael R Chase, Dang Thi Minh Ha, Phan Vuong Khac Thai, Nguyen Huu Lan, Do Dang Anh Thu, Nguyen Le Quang, Jessica Brown, Nathan D Hicks, Xin Wang, Maximillian Marin, Nicole C Howard, Andrew J Vickers, Wik
2024-05-09 [Comment] Pooled profiling of natural Mycobacterium tuberculosis diversity: linking genes, bacterial behaviours, and clinical outcomes Lucas Boeck
2024-05-09 [Correspondence] Used antigenic devices as a matrix for molecular detection of respiratory viruses Jean-Michel Mansuy, Emma Da Horta, Camille Bréhin, Isabelle Claudet, Pauline Trémeaux
2024-05-08 [Articles] Effect of human H3N2 influenza virus reassortment on influenza incidence and severity during the 2017–18 influenza season in the USA: a retrospective observational genomic analysis Hsuan Liu, Kathryn Shaw-Saliba, Jason Westerbeck, David Jacobs, Katherine Fenstermacher, Chia-Yu Chao, Yu-Nong Gong, Harrison Powell, Zexu Ma, Thomas Mehoke, Amanda W Ernlund, Amanda Dziedzic, Siddhant Vyas, Jared Evans, Lauren M Sauer, Chin-Chieh Wu, Shu
2024-05-08 [Review] Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases Saverio Caini, Adam Meijer, Marta C Nunes, Laetitia Henaff, Malaika Zounon, Bronke Boudewijns, Marco Del Riccio, John Paget
2024-05-08 [Articles] Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study Thomas G Evans, Flora Castellino, Monika Kowalik Dobczyk, Gwen Tucker, Ana Marie Walley, Katrin Van Leuven, Jelle Klein, Kathryn Rutkowski, Chris Ellis, Elizabeth Eagling-Vose, John Treanor, Carel van Baalen, Ella Filkov, Cyril Laurent, Juilee Thacker, Ja
2024-05-06 [Correspondence] Additional thoughts on group A streptococci Dingle Yu, Yuejie Zheng, George Fu Gao, Yonghong Yang
2024-05-02 [Articles] Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical tri Almahamoudou Mahamar, Merel J Smit, Koualy Sanogo, Youssouf Sinaba, Sidi M Niambele, Adama Sacko, Oumar M Dicko, Makonon Diallo, Seydina O Maguiraga, Yaya Sankaré, Sekouba Keita, Siaka Samake, Adama Dembele, Kjerstin Lanke, Rob ter Heine, John Bradley, Ya
2024-05-01 [Articles] Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study Susan Jackson, Julia L Marshall, Andrew Mawer, Raquel Lopez-Ramon, Stephanie A Harris, Iman Satti, Eileen Hughes, Hannah Preston-Jones, Ingrid Cabrera Puig, Stephanie Longet, Tom Tipton, Stephen Laidlaw, Rebecca Powell Doherty, Hazel Morrison, Robert Mitc
2024-04-26 [Articles] Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case–control study Annika Saukkoriipi, Natalie C Silmon de Monerri, Maija Toropainen, Laura Lindholm, Riitta Veijola, Jorma Toppari, Mikael Knip, David Radley, Emily Gomme, Babalwa Jongihlati, Annaliesa S Anderson, Arto A Palmu, Raphael Simon
2024-04-25 [Articles] Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study Rémy A Bonnin, Elodie Creton, Amandine Perrin, Delphine Girlich, Cecile Emeraud, Agnès B Jousset, Mathilde Duque, Aymeric Jacquemin, Katie Hopkins, Pierre Bogaerts, Youri Glupczynski, Niels Pfennigwerth, Marek Gniadkowski, Antoni P A Hendrickx, Kim van de
2024-04-25 [Editorial] The AMR brain drain The Lancet Microbe
2024-04-24 [Correspondence] Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition Soraya Maria Menezes, Marc Jamoulle, Maria Paula Carletto, Leen Moens, Isabelle Meyts, Piet Maes, Johan Van Weyenbergh
2024-04-23 [Correspondence] Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis Florian Reizine, Jean-Marc Tadié, Murielle Grégoire, Karin Tarte, Jean-Pierre Gangneux
2024-04-22 [Comment] Epidemiology of group A streptococcal infection: are we ready for a new scenario? Miriam Massese, Marilena La Sorda, Flavio De Maio, Antonio Gatto, Roberto Rosato, Valeria Pansini, Anya Caroselli, Barbara Fiori, Maurizio Sanguinetti, Antonio Chiaretti, Brunella Posteraro
2024-04-20 [Comment] Shared immunogenic epitopes between host entry and exit proteins from monkeypox and Alaskapox viruses Leonardo Pereira de Araújo, Evandro Neves Silva, Patrícia Paiva Corsetti, Leonardo Augusto de Almeida
2024-04-20 [Corrections] Correction to Lancet Microbe 2022; 3: e644
2024-04-20 [Corrections] Correction to Lancet Microbe 2023; 4: e931–42
2024-04-18 [Correspondence] Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China Yan Chen, Xi Li, Ying Fu, Yunsong Yu, Hua Zhou
2024-04-17 [Comment] Risks of releasing imperfect Wolbachia strains for arbovirus control Henrik Salje, Francis M Jiggins
2024-04-12 [Articles] Optimisation and evaluation of viral genomic sequencing of SARS-CoV-2 rapid diagnostic tests: a laboratory and cohort-based study Jillian S Paull, Brittany A Petros, Taylor M Brock-Fisher, Samantha A Jalbert, Victoria M Selser, Katelyn S Messer, Sabrina T Dobbins, Katherine C DeRuff, Davy Deng, Michael Springer, Pardis C Sabeti
2024-04-10 [Articles] Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study Daniel Golparian, Michelle J Cole, Leonor Sánchez-Busó, Michaela Day, Susanne Jacobsson, Thinushaa Uthayakumaran, Raquel Abad, Beatrice Bercot, Dominique A Caugant, Dagmar Heuer, Klaus Jansen, Sonja Pleininger, Paola Stefanelli, David M Aanensen, Benjamin
2024-04-10 [Personal View] Integrating research on bacterial pathogens and commensals to fight infections—an ecological perspective Lisa Maier, Christoph Stein-Thoeringer, Ruth E Ley, Heike Brötz-Oesterhelt, Hannes Link, Nadine Ziemert, Samuel Wagner, Andreas Peschel
2024-04-09 [Personal View] The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation Giacomo Casalini, Andrea Giacomelli, Spinello Antinori
2024-04-09 [Articles] Xpert MTB/RIF Ultra versus mycobacterial growth indicator tube liquid culture for detection of Mycobacterium tuberculosis in symptomatic adults: a diagnostic accuracy study Yingda L Xie, Christie Eichberg, Nchimunya Hapeela, Elizabeth Nakabugo, Irene Anyango, Kiranjot Arora, Jeffrey E Korte, Ronald Odero, Judi van Heerden, Widaad Zemanay, Samuel Kennedy, Pamela Nabeta, Mahmud Hanif, Camilla Rodrigues, Alena Skrahina, Wendy S
2024-04-08 [Review] Infectious diseases and the role of needle biopsy post-mortem Lucia Molinengo, Theodore Estrin-Serlui, Brian Hanley, Michael Osborn, Robert Goldin
2024-04-04 [Articles] Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis Karen M Elias, Shanchita R Khan, Eva Stadler, Timothy E Schlub, Deborah Cromer, Mark N Polizzotto, Stephen J Kent, Tari Turner, Miles P Davenport, David S Khoury
2024-04-04 [Correspondence] Concerted efforts toward genomic surveillance of viral pathogens in immunocompromised individuals Matheus Filgueira Bezerra, Gabriel da Luz Wallau
2024-04-03 [Correspondence] Are low-income and middle-income countries being neglected in genomic surveillance of the emergence and spread of multidrug-resistant Enterobacterales? Dennis Nurjadi, Sébastien Boutin, Thirumalaisamy P Velavan
2024-03-28 [Articles] Seroprevalence of Bas-Congo virus in Mangala, Democratic Republic of the Congo: a population-based cross-sectional study Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Takanari Hattori, Takeshi Saito, Boniface Pongombo Lombe, Hiroko Miyamoto, Akina Mori-Kajihara, Masahiro Kajihara, Agathe Bikupe Nkoy, Augustin Tshibwabwa Twabela, Justin Masumu, Steve Ahuka-Mundeke, Jean
2024-03-26 [Articles] Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study Natalia Maldonado, Inmaculada López-Hernández, Andrea García-Montaner, Luis Eduardo López-Cortés, Pedro María Martínez Pérez-Crespo, Pilar Retamar-Gentil, Adrián Sousa-Domínguez, Josune Goikoetxea, Ángeles Pulido-Navazo, Cristina Labayru-Echeverría, Clara

匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选